Peter B. Jones
Pharmacology · 2002–2021
A researcher in the Science corpus: 14 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 28 citations into it
- Epidemiology — 25 citations into it
- Statistics and Probability — 8 citations into it
Whom Peter B. Jones trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Peter B. Jones overall
Papers from Peter B. Jones's perspective
Ordered by how strongly the researchers Peter B. Jones trusts endorse each paper. Same corpus, a different order for every researcher.
- Impact of In-Scanner Head Motion on Multiple Measures of Functional Connectivity: Relevance for Studies of Neurodevelopment in Youth (NeuroImage)
- The Influence of Head Motion on Intrinsic Functional Connectivity MRI (NeuroImage)
- Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies (NeuroImage)
- Why do many psychiatric disorders emerge during adolescence? (Nature Reviews Neuroscience)
- Differentiating BOLD and Non-BOLD Signals in fMRI Time Series Using Multi-Echo EPI (NeuroImage)
- An Improved Framework for Confound Regression and Filtering for Control of Motion Artifact in the Preprocessing of Resting-State Functional Connectivity Data (NeuroImage)
- Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion (NeuroImage)
- Blipped-Controlled Aliasing in Parallel Imaging (blipped-CAIPI) for simultaneous multi-slice EPI with reduced g-factor penalty (Magnetic Resonance in Medicine)
- Whole-brain anatomical networks: Does the choice of nodes matter? (NeuroImage)
- A Comprehensive Assessment of Regional Variation in the Impact of Head Micromovements on Functional Connectomics (NeuroImage)
Their papers
- Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies (2021) — 3,026 citations
- The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study (2019) — 654 citations
- Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels (2019) — 617 citations
- Morphometric Similarity Networks Detect Microscale Cortical Organisation And Predict Inter-Individual Cognitive Variation (2017) — 404 citations
- Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment (2015) — 756 citations
- Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life (2014) — 802 citations
- A wavelet method for modeling and despiking motion artifacts from resting-state fMRI time series (2014) — 374 citations
- Adult mental health disorders and their age at onset (2013) — 676 citations
- Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. (2007) — 2,201 citations
- Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). (2006) — 1,057 citations
- Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. (2005) — 1,517 citations
- The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia (2003) — 661 citations
- Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. (2003) — 936 citations
- Obstetric complications and schizophrenia: historical and meta-analytic review. (2002) — 1,131 citations